首页 > 最新文献

Sonography最新文献

英文 中文
Differentiating right ventricular remodelling from cardiac pathology in athletes 鉴别运动员右心室重构与心脏病理
IF 0.4 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2022-01-22 DOI: 10.1002/sono.12299
Richard P. Allwood
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a leading cause of sudden cardiac death in young people and athletes. Prominent right ventricular remodelling can occur in highly trained endurance athletes, raising concern about underlying right ventricular pathology, such as ARVC. Distinguishing between physiological adaptation and cardiac pathology in athletes can be challenging, particularly in elite endurance athletes. This article describes a systematic approach used in sports cardiology to review the physiological adaptation of the right ventricle to exercise and the overlap with ARVC, focusing on the diagnostic investigations used to distinguish between athlete's heart and ARVC.
心律失常性右室心肌病(ARVC)是年轻人和运动员心脏性猝死的主要原因。高度训练的耐力运动员可能出现明显的右心室重构,这引起了人们对潜在右心室病理的关注,如ARVC。区分运动员的生理适应和心脏病理是具有挑战性的,特别是在优秀的耐力运动员中。本文描述了一种在运动心脏病学中使用的系统方法来回顾右心室对运动的生理适应以及与ARVC的重叠,重点是用于区分运动员心脏和ARVC的诊断调查。
{"title":"Differentiating right ventricular remodelling from cardiac pathology in athletes","authors":"Richard P. Allwood","doi":"10.1002/sono.12299","DOIUrl":"https://doi.org/10.1002/sono.12299","url":null,"abstract":"Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a leading cause of sudden cardiac death in young people and athletes. Prominent right ventricular remodelling can occur in highly trained endurance athletes, raising concern about underlying right ventricular pathology, such as ARVC. Distinguishing between physiological adaptation and cardiac pathology in athletes can be challenging, particularly in elite endurance athletes. This article describes a systematic approach used in sports cardiology to review the physiological adaptation of the right ventricle to exercise and the overlap with ARVC, focusing on the diagnostic investigations used to distinguish between athlete's heart and ARVC.","PeriodicalId":29898,"journal":{"name":"Sonography","volume":"5 1","pages":"62 - 72"},"PeriodicalIF":0.4,"publicationDate":"2022-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75470266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound estimation of fetal weight accuracy in a regional hospital: A retrospective audit 超声估计胎儿体重准确性在地区医院:回顾性审计
IF 0.4 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2022-01-11 DOI: 10.1002/sono.12296
J. Spurway, Casey Filce, G. Luscombe
Ultrasound estimated fetal weight (EFW) is a vital part of prenatal care. We aimed to determine the accuracy of sonographic EFW at a regional Australian hospital, explore factors associated with EFW accuracy and review accuracy calculation methods.
超声估计胎儿体重(EFW)是产前护理的重要组成部分。我们旨在确定澳大利亚一家地区医院超声EFW的准确性,探讨与EFW准确性相关的因素,并回顾准确性的计算方法。
{"title":"Ultrasound estimation of fetal weight accuracy in a regional hospital: A retrospective audit","authors":"J. Spurway, Casey Filce, G. Luscombe","doi":"10.1002/sono.12296","DOIUrl":"https://doi.org/10.1002/sono.12296","url":null,"abstract":"Ultrasound estimated fetal weight (EFW) is a vital part of prenatal care. We aimed to determine the accuracy of sonographic EFW at a regional Australian hospital, explore factors associated with EFW accuracy and review accuracy calculation methods.","PeriodicalId":29898,"journal":{"name":"Sonography","volume":"2085 1","pages":"33 - 39"},"PeriodicalIF":0.4,"publicationDate":"2022-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86551357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors influencing duration of neonatal cranial ultrasound: A pilot study of retrospective data 影响新生儿颅超声持续时间的因素:回顾性资料的初步研究
IF 0.4 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2021-12-10 DOI: 10.1002/sono.12297
Naomi Dare, Mary‐Anne Ramis
Cranial ultrasound is frequently used for diagnostic and/or routine screening in neonates. Exploring factors associated with scan duration is warranted to ensure alignment to clinical guidelines.
颅超声常用于新生儿的诊断和/或常规筛查。探索与扫描时间相关的因素是必要的,以确保符合临床指南。
{"title":"Factors influencing duration of neonatal cranial ultrasound: A pilot study of retrospective data","authors":"Naomi Dare, Mary‐Anne Ramis","doi":"10.1002/sono.12297","DOIUrl":"https://doi.org/10.1002/sono.12297","url":null,"abstract":"Cranial ultrasound is frequently used for diagnostic and/or routine screening in neonates. Exploring factors associated with scan duration is warranted to ensure alignment to clinical guidelines.","PeriodicalId":29898,"journal":{"name":"Sonography","volume":"12 1","pages":"49 - 53"},"PeriodicalIF":0.4,"publicationDate":"2021-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84412280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Routine disclosure statements about ultrasound examinations during Covid‐19 pandemic are unhelpful and should be avoided Covid - 19大流行期间关于超声检查的常规披露声明没有帮助,应避免
IF 0.4 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2021-11-24 DOI: 10.1002/sono.12295
M. Necas
Various routine disclosure statements relating to the performance of ultrasound (US) during the COVID‐19 pandemic are finding their way into radiology reports. These statements usually suggest that US examinations during the pandemic, or on a COVID‐19 positive patient, are somehow limited and urge the clinicians to reflect on these considerations when accepting radiology reports. However, such disclosure statements are generally unhelpful to clinicians and are not consistent with the realities of current clinical US practice. This article provides a critique of these disclosure statements and concludes by discouraging sonographers and radiologists from making such statements as a routine part of their clinical ultrasound reports.
在COVID - 19大流行期间,与超声(US)性能有关的各种常规披露声明正在进入放射学报告。这些声明通常表明,在大流行期间或对COVID - 19阳性患者的美国检查在某种程度上是有限的,并敦促临床医生在接受放射学报告时反思这些考虑因素。然而,这样的披露声明通常对临床医生没有帮助,并且与当前美国临床实践的现实不一致。这篇文章提供了对这些披露声明的批评,并通过劝阻超声医师和放射科医生将此类声明作为其临床超声报告的常规部分来总结。
{"title":"Routine disclosure statements about ultrasound examinations during Covid‐19 pandemic are unhelpful and should be avoided","authors":"M. Necas","doi":"10.1002/sono.12295","DOIUrl":"https://doi.org/10.1002/sono.12295","url":null,"abstract":"Various routine disclosure statements relating to the performance of ultrasound (US) during the COVID‐19 pandemic are finding their way into radiology reports. These statements usually suggest that US examinations during the pandemic, or on a COVID‐19 positive patient, are somehow limited and urge the clinicians to reflect on these considerations when accepting radiology reports. However, such disclosure statements are generally unhelpful to clinicians and are not consistent with the realities of current clinical US practice. This article provides a critique of these disclosure statements and concludes by discouraging sonographers and radiologists from making such statements as a routine part of their clinical ultrasound reports.","PeriodicalId":29898,"journal":{"name":"Sonography","volume":"2 1","pages":"3 - 6"},"PeriodicalIF":0.4,"publicationDate":"2021-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84434699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three‐dimensional gynaecological ultrasound, part one: How, when and why? 三维妇科超声,第一部分:如何,何时和为什么?
IF 0.4 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2021-11-14 DOI: 10.1002/sono.12294
A. Deslandes, Anthea Croft, C. Panuccio
Most high‐end ultrasound systems now incorporate three‐dimensional imaging as a standard feature. As such, the use of three‐dimensional ultrasound is becoming routine in many facets of medical ultrasound, especially obstetrics and gynaecology. Three‐dimensional ultrasound can enhance or even alter a diagnosis in many gynaecological pathologies. However, like any technique, the usefulness and accuracy of the application relies on the operator having adequate application knowledge and technical acquisition skills to be able to use it to its full potential. This is the first part of a two‐part series on this topic. This article serves to educate sonographers and other ultrasound users on how to incorporate a three‐dimensional ultrasound assessment into their routine gynaecological examinations, why this should be done and how to overcome some of the pitfalls encountered with this technique.
现在大多数高端超声系统都将三维成像作为标准功能。因此,三维超声在医学超声的许多方面,特别是产科和妇科的使用正在成为常规。三维超声可以增强甚至改变许多妇科疾病的诊断。然而,像任何技术一样,应用程序的有用性和准确性依赖于操作员具有足够的应用知识和技术获取技能,以便能够充分利用它。这是关于这个话题的两部分系列文章的第一部分。本文旨在教育超声医师和其他超声用户如何将三维超声评估纳入他们的常规妇科检查,为什么要这样做,以及如何克服这种技术遇到的一些陷阱。
{"title":"Three‐dimensional gynaecological ultrasound, part one: How, when and why?","authors":"A. Deslandes, Anthea Croft, C. Panuccio","doi":"10.1002/sono.12294","DOIUrl":"https://doi.org/10.1002/sono.12294","url":null,"abstract":"Most high‐end ultrasound systems now incorporate three‐dimensional imaging as a standard feature. As such, the use of three‐dimensional ultrasound is becoming routine in many facets of medical ultrasound, especially obstetrics and gynaecology. Three‐dimensional ultrasound can enhance or even alter a diagnosis in many gynaecological pathologies. However, like any technique, the usefulness and accuracy of the application relies on the operator having adequate application knowledge and technical acquisition skills to be able to use it to its full potential. This is the first part of a two‐part series on this topic. This article serves to educate sonographers and other ultrasound users on how to incorporate a three‐dimensional ultrasound assessment into their routine gynaecological examinations, why this should be done and how to overcome some of the pitfalls encountered with this technique.","PeriodicalId":29898,"journal":{"name":"Sonography","volume":"172 1","pages":"15 - 7"},"PeriodicalIF":0.4,"publicationDate":"2021-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74547883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three‐dimensional gynaecological ultrasound part two: A pictorial essay 三维妇科超声第二部分:图片文章
IF 0.4 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2021-11-14 DOI: 10.1002/sono.12293
A. Deslandes, Anthea Croft, C. Panuccio
Three‐dimensional ultrasound (3DUS) is becoming a standard part of obstetric and gynaecological ultrasound examinations. With most high‐end ultrasound systems now incorporating three‐dimensional functionality, the technology can be used to enhance and/or confirm a diagnosis in many gynaecological pathologies. Part one of this two‐part series covered the technical aspects of performing three‐dimensional gynaecological ultrasound. This paper, part two, presents a pictorial essay of 3DUS in gynaecological imaging serving to educate sonographers and other ultrasound users on the typical appearance of some common, and not so common ultrasound findings.
三维超声(3DUS)正在成为产科和妇科超声检查的标准部分。现在大多数高端超声系统都具有三维功能,该技术可用于增强和/或确认许多妇科疾病的诊断。这两部分系列的第一部分涵盖了执行三维妇科超声的技术方面。本文第二部分,介绍了3DUS在妇科成像中的图像文章,用于教育超声医师和其他超声用户对一些常见和不常见超声结果的典型外观。
{"title":"Three‐dimensional gynaecological ultrasound part two: A pictorial essay","authors":"A. Deslandes, Anthea Croft, C. Panuccio","doi":"10.1002/sono.12293","DOIUrl":"https://doi.org/10.1002/sono.12293","url":null,"abstract":"Three‐dimensional ultrasound (3DUS) is becoming a standard part of obstetric and gynaecological ultrasound examinations. With most high‐end ultrasound systems now incorporating three‐dimensional functionality, the technology can be used to enhance and/or confirm a diagnosis in many gynaecological pathologies. Part one of this two‐part series covered the technical aspects of performing three‐dimensional gynaecological ultrasound. This paper, part two, presents a pictorial essay of 3DUS in gynaecological imaging serving to educate sonographers and other ultrasound users on the typical appearance of some common, and not so common ultrasound findings.","PeriodicalId":29898,"journal":{"name":"Sonography","volume":"15 1","pages":"73 - 82"},"PeriodicalIF":0.4,"publicationDate":"2021-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90127041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of congenital heart disease (CHD) in the first trimester 妊娠早期先天性心脏病(CHD)的检测
IF 0.4 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2021-11-11 DOI: 10.1002/sono.12290
A. Lee‐Tannock
I read with interest the narrative review article on the detection of congenital heart disease (CHD) in the first trimester by Dudnikov, Quinton and Alphonse published in the June issue of Sonography. Undoubtedly, a great deal of work has gone into preparing this article, and I commend the authors for this. Still, I feel that the high detection rates quoted are overstated, particularly for the low-risk population. The authors do state this and some other limitations, but these limitations need more emphasis. In addition, the methodologies of some of the reviewed articles vary greatly and pooling heterogeneous studies increases the risk of significant bias. For example, the detection rate calculation included studies that used only cardiac imaging signs, whereas other studies included non-cardiac signs, for example, nuchal translucency (NT), ductus waveform. Another paper compared 2D imaging and 4D STIC in detecting CHD in a high-risk population. Some congenital cardiac anomalies evolve during pregnancy and are not evident in the first trimester (e.g., aortic senosis). Additionally, other anomalies are present and easily diagnosable (e.g., hypoplastic left heart syndrome) compared to those that are less obvious (e.g., atrioventricular defect). The skill level of sonographers performing first trimester combine screening (FTCS) is also an important consideration. To perform this type of imaging NT certification is required, and to maintain it, sonographers need to demonstrate an ongoing high standard via annual audits. Not all sonographers performing obstetric imaging have this certification. This system does not exist for morphology imaging and could partially explain the discrepancy in detection rates between the two examinations. There is also a need to differentiate between a screening examination (where the heart is thought to be abnormal) and fetal echocardiography (where a cardiac diagnosis is made and counselling of the condition provided) in the first trimester. Most patients referred for early fetal echocardiography are due to concerns at a screening examination, and only a few are because of a previous baby with CHD. In a recent meta-analysis and systematic review, Yu et al. reported a detection rate for CHD at 75% using fetal echocardiography in a high-risk population. This rate also includes false positive and false negative diagnoses. In my 20+ years of performing fetal and paediatric echocardiography with some very experienced paediatric cardiologists, a definitive diagnosis in complex cases is not made until the postnatal period and/or at cardiac surgery. Another potential confounder is the lack of post-mortem data if a pregnancy is terminated based on scan findings alone. Results of detection of CHD at routine FTCS in the low-risk population are quoted at 60%–63%. Of note, none of the reviewed studies was on an Australian or American population where obesity is more prevalent than in Europe. I support screening for CHD at the first-
我饶有兴趣地阅读了Dudnikov、Quinton和Alphonse在《超声检查》(Sonography)杂志6月刊上发表的关于早期妊娠期先天性心脏病(CHD)检测的叙述性综述文章。毫无疑问,为准备这篇文章做了大量的工作,我为此赞扬作者。尽管如此,我还是觉得所谓的高检出率被夸大了,尤其是对低风险人群而言。作者确实说明了这一点和其他一些限制,但这些限制需要更多的强调。此外,一些综述文章的方法差异很大,汇集异质研究增加了显著偏倚的风险。例如,检出率计算包括仅使用心脏影像学征象的研究,而其他研究包括非心脏征象,例如颈透明(NT)、导管波形。另一篇论文比较了二维成像和四维STIC在高危人群中检测冠心病的效果。一些先天性心脏异常是在怀孕期间发生的,在妊娠早期并不明显(如主动脉瓣病变)。此外,与那些不太明显的异常(如房室缺损)相比,其他异常(如左心发育不全综合征)是存在的且容易诊断的。超声医师进行妊娠早期联合筛查(FTCS)的技能水平也是一个重要的考虑因素。要执行这种类型的成像NT认证是必需的,并保持它,超声医师需要通过年度审核证明持续的高标准。并非所有进行产科成像的超声医师都有这一证书。该系统不存在形态学成像,可以部分解释两种检查之间检出率的差异。在妊娠早期,还需要区分筛查检查(认为心脏异常)和胎儿超声心动图检查(做出心脏诊断并提供病情咨询)。大多数患者进行早期胎儿超声心动图检查是由于对筛查检查的担忧,只有少数患者是因为先前的婴儿患有冠心病。在最近的一项荟萃分析和系统综述中,Yu等人报道了在高危人群中使用胎儿超声心动图检测冠心病的检出率为75%。这一比率还包括假阳性和假阴性诊断。在我与一些非常有经验的儿科心脏病专家一起进行胎儿和儿科超声心动图的20多年中,直到产后和/或心脏手术时才能对复杂病例做出明确的诊断。另一个潜在的混杂因素是,如果仅根据扫描结果终止妊娠,则缺乏尸检数据。在低危人群中,常规FTCS检测冠心病的结果为60%-63%。值得注意的是,没有一项研究是针对澳大利亚或美国人群的,而这些人群的肥胖比欧洲人更普遍。我支持在妊娠早期检查时进行冠心病筛查。然而,我强烈要求在声称高检出率和准确诊断是现实的早期妊娠与一些病变和人群谨慎。这样的索赔可能会增加额外的工作量压力,并增加超声检查人员的诉讼风险,这是一个真正的危险。你的真诚
{"title":"Detection of congenital heart disease (CHD) in the first trimester","authors":"A. Lee‐Tannock","doi":"10.1002/sono.12290","DOIUrl":"https://doi.org/10.1002/sono.12290","url":null,"abstract":"I read with interest the narrative review article on the detection of congenital heart disease (CHD) in the first trimester by Dudnikov, Quinton and Alphonse published in the June issue of Sonography. Undoubtedly, a great deal of work has gone into preparing this article, and I commend the authors for this. Still, I feel that the high detection rates quoted are overstated, particularly for the low-risk population. The authors do state this and some other limitations, but these limitations need more emphasis. In addition, the methodologies of some of the reviewed articles vary greatly and pooling heterogeneous studies increases the risk of significant bias. For example, the detection rate calculation included studies that used only cardiac imaging signs, whereas other studies included non-cardiac signs, for example, nuchal translucency (NT), ductus waveform. Another paper compared 2D imaging and 4D STIC in detecting CHD in a high-risk population. Some congenital cardiac anomalies evolve during pregnancy and are not evident in the first trimester (e.g., aortic senosis). Additionally, other anomalies are present and easily diagnosable (e.g., hypoplastic left heart syndrome) compared to those that are less obvious (e.g., atrioventricular defect). The skill level of sonographers performing first trimester combine screening (FTCS) is also an important consideration. To perform this type of imaging NT certification is required, and to maintain it, sonographers need to demonstrate an ongoing high standard via annual audits. Not all sonographers performing obstetric imaging have this certification. This system does not exist for morphology imaging and could partially explain the discrepancy in detection rates between the two examinations. There is also a need to differentiate between a screening examination (where the heart is thought to be abnormal) and fetal echocardiography (where a cardiac diagnosis is made and counselling of the condition provided) in the first trimester. Most patients referred for early fetal echocardiography are due to concerns at a screening examination, and only a few are because of a previous baby with CHD. In a recent meta-analysis and systematic review, Yu et al. reported a detection rate for CHD at 75% using fetal echocardiography in a high-risk population. This rate also includes false positive and false negative diagnoses. In my 20+ years of performing fetal and paediatric echocardiography with some very experienced paediatric cardiologists, a definitive diagnosis in complex cases is not made until the postnatal period and/or at cardiac surgery. Another potential confounder is the lack of post-mortem data if a pregnancy is terminated based on scan findings alone. Results of detection of CHD at routine FTCS in the low-risk population are quoted at 60%–63%. Of note, none of the reviewed studies was on an Australian or American population where obesity is more prevalent than in Europe. I support screening for CHD at the first-","PeriodicalId":29898,"journal":{"name":"Sonography","volume":"36 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2021-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89141244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The detection of first trimester ultrasound in the diagnosis of congenital heart defects: A narrative review 妊娠早期超声在先天性心脏缺陷诊断中的应用综述
IF 0.4 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2021-11-09 DOI: 10.1002/sono.12292
A. Quinton, J. Alphonse, Oleksandr Dudnikov
The authors of the article “The detection of first trimester ultrasound in the diagnosis of congenital heart defects: A narrative review” published in Sonography, would like to thank the author/s of the letter to the editor for their kind comments and for taking the time to respond to our work. We agree the studies reviewed were heterogenous in nature and for this reason the results were not pooled but were presented as mean values and ranges as has been recommended. We presented a list of congenital heart defects (CHD) that were detected or missed in the first trimester stating fetal heart size as one reason CHD is missed. We acknowledge evolution of CHD as suggested would have strengthened our argument. We also agree that lack of follow-up after CHD diagnosis is problematic when reporting the results of studies. While the skill level of a sonographer performing a first trimester ultrasound and the use of first trimester combined screening by a nuchal translucency ultrasound education and monitoring program (NTUEMP) certified sonographer, utilising tools such as nuchal translucency, ductus venosus and nasal bone assessment may improve the detection of CHD, we are unaware of any evidence that suggests a relationship between NTUEMP certification and the ability to scan the fetal heart. Furthermore, NTUEMP does not include formal assessment of the fetal heart in the course content nor in reaccredidation. Of the 6908 Australian accredited sonographers only 23% are currently nuchal translucency accredited. Indeed, operator training for heart screening views appears to be a major determinant for successful screening for CHD. Recent work suggests intention to perform screening is also important. This highlights the importance of education for sonographers for first trimester screening of the fetal heart. We agree there is a need to differentiate between screening for CHD and a diagnostic fetal echocardiography scan in the first trimester. We also agree that claiming high-detection rates for CHD screening in the first trimester is problematic. Our review of the current literature concluded the results would not be generalisable to low-risk general radiology or obstetric practices as the majority of first trimester CHD studies were performed by paediatric cardiologists. Further research is needed to determine if education, training, and intention to assess the fetal heart in the first trimester will improve detection rates in low-risk populations when scans are performed by general sonographers.
发表在《超声》杂志上的文章《妊娠早期超声在先天性心脏缺陷诊断中的检测:叙述性回顾》的作者们,想要感谢给编辑的信的作者们的友好评论和花时间回复我们的工作。我们同意审查的研究本质上是异质性的,因此结果没有汇总,而是按照建议的平均值和范围呈现。我们提出了先天性心脏缺陷(CHD)的清单,被发现或遗漏在孕早期指出胎儿心脏大小的一个原因是遗漏了冠心病。我们承认冠心病的进化会加强我们的论点。我们也同意在报告研究结果时缺乏冠心病诊断后的随访是有问题的。虽然超声医师进行早期妊娠超声检查的技能水平和使用早期妊娠联合筛查由颈部半透明超声教育和监测计划(NTUEMP)认证的超声医师,利用诸如颈部半透明、静脉导管和鼻骨评估等工具可以提高冠心病的检测,但我们不知道有任何证据表明NTUEMP认证与扫描胎儿心脏的能力之间存在关系。此外,NTUEMP在课程内容和重新认证中不包括对胎儿心脏的正式评估。在6908名澳大利亚认可的超声技师中,目前只有23%的人获得了颈部半透明认证。事实上,心脏筛查方面的操作员培训似乎是成功筛查冠心病的主要决定因素。最近的研究表明,进行筛查的意愿也很重要。这突出了教育的重要性超声检查胎儿心脏的早期三个月筛选。我们同意有必要区分筛查冠心病和诊断胎儿超声心动图扫描在前三个月。我们也同意声称在妊娠早期进行冠心病筛查的高检出率是有问题的。我们对现有文献的回顾得出结论,该结果不能推广到低风险的普通放射学或产科实践,因为大多数妊娠早期冠心病研究是由儿科心脏病专家进行的。需要进一步的研究来确定教育、培训和在妊娠早期评估胎儿心脏的意愿是否会提高低风险人群在普通超声检查时的检出率。
{"title":"The detection of first trimester ultrasound in the diagnosis of congenital heart defects: A narrative review","authors":"A. Quinton, J. Alphonse, Oleksandr Dudnikov","doi":"10.1002/sono.12292","DOIUrl":"https://doi.org/10.1002/sono.12292","url":null,"abstract":"The authors of the article “The detection of first trimester ultrasound in the diagnosis of congenital heart defects: A narrative review” published in Sonography, would like to thank the author/s of the letter to the editor for their kind comments and for taking the time to respond to our work. We agree the studies reviewed were heterogenous in nature and for this reason the results were not pooled but were presented as mean values and ranges as has been recommended. We presented a list of congenital heart defects (CHD) that were detected or missed in the first trimester stating fetal heart size as one reason CHD is missed. We acknowledge evolution of CHD as suggested would have strengthened our argument. We also agree that lack of follow-up after CHD diagnosis is problematic when reporting the results of studies. While the skill level of a sonographer performing a first trimester ultrasound and the use of first trimester combined screening by a nuchal translucency ultrasound education and monitoring program (NTUEMP) certified sonographer, utilising tools such as nuchal translucency, ductus venosus and nasal bone assessment may improve the detection of CHD, we are unaware of any evidence that suggests a relationship between NTUEMP certification and the ability to scan the fetal heart. Furthermore, NTUEMP does not include formal assessment of the fetal heart in the course content nor in reaccredidation. Of the 6908 Australian accredited sonographers only 23% are currently nuchal translucency accredited. Indeed, operator training for heart screening views appears to be a major determinant for successful screening for CHD. Recent work suggests intention to perform screening is also important. This highlights the importance of education for sonographers for first trimester screening of the fetal heart. We agree there is a need to differentiate between screening for CHD and a diagnostic fetal echocardiography scan in the first trimester. We also agree that claiming high-detection rates for CHD screening in the first trimester is problematic. Our review of the current literature concluded the results would not be generalisable to low-risk general radiology or obstetric practices as the majority of first trimester CHD studies were performed by paediatric cardiologists. Further research is needed to determine if education, training, and intention to assess the fetal heart in the first trimester will improve detection rates in low-risk populations when scans are performed by general sonographers.","PeriodicalId":29898,"journal":{"name":"Sonography","volume":"25 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2021-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83951231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An audit of inter‐hospital transfers of children with abdominal pain and their associated medical imaging findings 对腹痛患儿的医院间转院及其相关医学影像学表现的审计
IF 0.4 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2021-10-27 DOI: 10.1002/sono.12291
T. Reddan, Toni Halligan, J. Corness
Ultrasound is a common first‐line examination in acute abdominal pain in children. In rural and regional areas, ultrasound is an important factor in decisions to transfer paediatric patients for tertiary care. Transfers can be over a considerable distance, by road and air, and at great cost. This audit reviewed ultrasound findings in children transferred to an Australian paediatric hospital for acute abdominal pain.
超声是儿童急性腹痛常见的一线检查方法。在农村和地区,超声是决定将儿科患者转到三级保健的重要因素。可以通过公路或飞机进行相当远的运输,而且费用很高。本审计回顾了因急性腹痛转至澳大利亚儿科医院的儿童的超声检查结果。
{"title":"An audit of inter‐hospital transfers of children with abdominal pain and their associated medical imaging findings","authors":"T. Reddan, Toni Halligan, J. Corness","doi":"10.1002/sono.12291","DOIUrl":"https://doi.org/10.1002/sono.12291","url":null,"abstract":"Ultrasound is a common first‐line examination in acute abdominal pain in children. In rural and regional areas, ultrasound is an important factor in decisions to transfer paediatric patients for tertiary care. Transfers can be over a considerable distance, by road and air, and at great cost. This audit reviewed ultrasound findings in children transferred to an Australian paediatric hospital for acute abdominal pain.","PeriodicalId":29898,"journal":{"name":"Sonography","volume":"131 1","pages":"23 - 28"},"PeriodicalIF":0.4,"publicationDate":"2021-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75909104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reducing unnecessary thyroid fine needle aspirations using American College of Radiology's thyroid imaging reporting and data system: A 5‐year retrospective audit 使用美国放射学会甲状腺成像报告和数据系统减少不必要的甲状腺细针穿刺:一项5年回顾性审计
IF 0.4 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2021-10-01 DOI: 10.1002/sono.12289
Christopher Hayes, Ya.G. Shvarts, Randhir Sewgolam, Tri Nguyen, S. Ussher
With the growing investigative imaging techniques available in medicine, increasing numbers of thyroid lesions are being identified, either symptomatically or as incidental findings. Ultrasonography remains a key first‐line investigation into evaluating these lesions, and accurately stratifying whether further investigation or management is required.
随着医学上可用的调查性成像技术的发展,越来越多的甲状腺病变被发现,无论是症状性的还是偶然发现的。超声检查仍然是评估这些病变的关键一线调查,并准确地分层是否需要进一步调查或治疗。
{"title":"Reducing unnecessary thyroid fine needle aspirations using American College of Radiology's thyroid imaging reporting and data system: A 5‐year retrospective audit","authors":"Christopher Hayes, Ya.G. Shvarts, Randhir Sewgolam, Tri Nguyen, S. Ussher","doi":"10.1002/sono.12289","DOIUrl":"https://doi.org/10.1002/sono.12289","url":null,"abstract":"With the growing investigative imaging techniques available in medicine, increasing numbers of thyroid lesions are being identified, either symptomatically or as incidental findings. Ultrasonography remains a key first‐line investigation into evaluating these lesions, and accurately stratifying whether further investigation or management is required.","PeriodicalId":29898,"journal":{"name":"Sonography","volume":"15 1","pages":"29 - 32"},"PeriodicalIF":0.4,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87493139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Sonography
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1